Cargando…
Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution
OBJECTIVE: To define headache characteristics and evolution in relation to COVID-19 and its inflammatory response. METHODS: This is a prospective study, comparing clinical data and inflammatory biomarkers of COVID-19 patients with and without headache, recruited at the Emergency Room. We compared ba...
Autores principales: | Caronna, Edoardo, Ballvé, Alejandro, Llauradó, Arnau, Gallardo, Victor José, Ariton, Diana María, Lallana, Sofia, López Maza, Samuel, Olivé Gadea, Marta, Quibus, Laura, Restrepo, Juan Luis, Rodrigo-Gisbert, Marc, Vilaseca, Andreu, Hernandez Gonzalez, Manuel, Martinez Gallo, Monica, Alpuente, Alicia, Torres-Ferrus, Marta, Pujol Borrell, Ricard, Alvarez-Sabin, José, Pozo-Rosich, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645597/ https://www.ncbi.nlm.nih.gov/pubmed/33146036 http://dx.doi.org/10.1177/0333102420965157 |
Ejemplares similares
-
Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months
por: Caronna, Edoardo, et al.
Publicado: (2021) -
In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study
por: Alpuente, Alicia, et al.
Publicado: (2021) -
Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA
por: Torres-Ferrus, Marta, et al.
Publicado: (2020) -
OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication Overuse
por: Caronna, Edoardo, et al.
Publicado: (2018) -
A study of differential microRNA expression profile in migraine: the microMIG exploratory study
por: Gallardo, V. J., et al.
Publicado: (2023)